Search
for
Sort by
Research 301–330 of 1000+
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing
- Alopecia areata and risk of atopic and autoimmune conditions: population-based cohort study
- Alopecia Areata: A possible extraintestinal manifestation of Crohn's disease
- Decreased CD200R expression on monocyte-derived macrophages correlates with Th17/Treg imbalance and disease activity in rheumatoid arthritis patients
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Response to ustekinumab in three pediatric patients with alopecia areata
- An update of the pathogenesis of frontal fibrosing alopecia: What does the current evidence tell us?
- The Anagen Hair Cycle Induces Systemic Immunosuppression of Contact Hypersensitivity in Mice
- The Contributory Roles of Th17 Lymphocyte and Cytotoxic T Lymphocyte at the Hair Bulge Region as Well as the Hair Bulb Area in the Chronic Alopecia Areata Patients
- The role of leptin in selected skin diseases
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata
- SIRT1 downregulation provokes immune-inflammatory responses in hair follicle outer root sheath cells and may contribute to development of alopecia areata
- Dupilumab and Alopecia Areata: A Possible Combined or Disturbance Therapy? A Review of the Literature
- Efficacy of the phosphodiesterase-4 inhibitor, apremilast, in a patient with severe alopecia areata
- A biopsy-sized 3D skin model with a perifollicular vascular plexus enables studying immune cell trafficking in the skin
- Janus Kinase Inhibitors against Other Biological Treatments in Alopecia Areata
- Advances in molecular pathogenesis of hidradenitis suppurativa: Dysregulated keratins and ECM signaling
- 544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1)
- Pruritus, Allergy and Autoimmunity: Paving the Way for an Integrated Understanding of Psychodermatological Diseases?
- A Potential Role for IL-4 and IL-13 in an Alopecia Areata–Like Phenotype: A Clinical Perspective
- Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies—A Narrative Review
- Alopecia Areata: A Complex Cytokine Driven Disease
- The Immunological Association between Alopecia Areata and Respiratory Diseases: A Systematic Review
- Pinkie, the First Viable Germline Hypomorph Allele of Retinoid X Receptor Alpha, Reveals an Important Role for RXRa in Th2 Development.
- A meta-analysis of chemokines in alopecia areata: recruiting immune cells toward the hair follicle
- Pathogenesis of paradoxical alopecia areata during dupilumab therapy: What is known and unknown
- Healthy individuals genetically at-risk for the development of Pemphigus vulgaris or Alopecia areata share disease-like cytokine dysregulation